Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2599 USD | +13.00% | +9.66% | -85.72% |
04-15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
04-12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.72% | 4.55M | |
+25.90% | 42.68B | |
-3.92% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.57% | 12.3B | |
-2.92% | 11.95B | |
-1.92% | 11.55B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Portage Biotech Fiscal Full-Year 2022 Net Loss Narrows